GSK is planning to invest £200m in its UK manufacturing operations over the next two years.
As part of the plans between 2023 and 2025, GSK will improve its UK sites, including constructing new facilities and assembly lines. Furthermore, the pharmaceutical giant will also invest £67m revamping one of its Scottish factories, based in Montrose. This investment will help GSK improve production of the ingredients used to make a range of…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
